Tysabri Brain Infection Case Dismissed; Label Adequate, Claims Preempted
Mealey's (August 15, 2016, 8:18 AM EDT) -- CAMBRIDGE, Mass. — A New York state court judge on July 28 granted summary judgment in a fatal Tysabri brain infection case, finding that the drug’s label warned of the injury the decedent suffered and a failure-to-warn claim is preempted by federal law (Gerald Gentile v. Biogen Idec, Inc., et al., No.1181-CV-03500, Mass. Super., Middlesex Co.; 2016 Mass. Super. LEXIS 238).
(Opinion available. Document #28-160818-007Z.)
In 1981, Diane Gentile of New York was diagnosed with multiple sclerosis (MS). In 2006, Gentile’s doctor, Bianca Weinstock-Guttman, M.D., a...